Triveni Bio
Biotechnology company (formerly Amagma Therapeutics) developing therapeutics for serious diseases including cancer and immune-mediated conditions.
Website
https://www.trivenibio.comLocation
Cambridge, Massachusetts, USA
Founded
2021
Investors
1
Categories
biotech, therapeutics, oncology, immunology
Notes
Triveni Bio (formerly known as Amagma Therapeutics) is a biotechnology company developing therapeutics for serious diseases. The company is headquartered in Cambridge, Massachusetts.
The company is focused on developing novel therapeutic approaches for cancer and other serious conditions, leveraging innovative drug discovery platforms and mechanisms of action.
Triveni Bio is backed by Polaris Partners, a leading healthcare-focused venture capital firm.
Team
- Leadership team information not publicly disclosed
Additional Research Findings
- Portfolio company of Polaris Partners
- Formerly known as Amagma Therapeutics
- Oncology and immunology focus
- Cambridge, Massachusetts headquarters
- Founded in 2021
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Polaris Partners | US | biotech-focused | - | 33 |